Search research articles
Contact Us
Filters
Showing results (141-150 of 217) with videos related to
Page
of 22
Sort By:
The Journal of Experimental Medicine
|
October 31, 2023
First-in-human therapy with Treg produced from thymic tissue (thyTreg) in a heart transplant infant
Esther Bernaldo-de-Quirós, Manuela Camino, Marta Martínez-Bonet, et al.
Therapeutic Advances in Musculoskeletal Disease
|
August 4, 2022
Risk of ischaemic stroke among new users of glucosamine and chondroitin sulphate: a nested case-control study
Ramón Mazzucchelli, Sara Rodríguez-Martín, Natalia Crespí-Villarías, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 18, 2022
Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma
Agostina Stradella, Pablo Gargallo, Mónica Cejuela, et al.
Data in Brief
|
July 17, 2025
PCPAm - A dataset of histopathological images of penile cancer for classification tasks
Marcos Gabriel Mendes Lauande, Geraldo Braz Júnior, João Dallyson Sousa de Almeida, et al.
Oncotarget
|
October 27, 2015
FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies
Antonio Martínez-Aranda, Vanessa Hernández, Emre Guney, et al.
Breast Cancer Research and Treatment
|
February 7, 2018
First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2- advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial
Wolfgang Janni, Emilio Alba, Thomas Bachelot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 6, 2022
Pre-operative ribociclib plus letrozole versus chemotherapy: Health-related quality of life outcomes from the SOLTI CORALLEEN trial
Guillermo Villacampa, Claudette Falato, Laia Paré, et al.
Neuro-Oncology
|
June 3, 2017
Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification
Juan Manuel Sepúlveda-Sánchez, María Ángeles Vaz, Carmen Balañá, et al.
Frontiers in Immunology
|
June 2, 2022
A Novel GMP Protocol to Produce High-Quality Treg Cells From the Pediatric Thymic Tissue to Be Employed as Cellular Therapy
Esther Bernaldo-de-Quirós, Beatriz Cózar, Rocío López-Esteban, et al.
Breast Cancer Research and Treatment
|
July 10, 2012
Efficacy and safety of concurrent trastuzumab plus weekly paclitaxel-FEC as primary therapy for HER2-positive breast cancer in everyday clinical practice
Sonia Pernas, Miguel Gil-Gil, María Ochoa de Olza, et al.
Page
of 22
Search research articles
Search
Showing results (141-150 of 217) with videos related to
Sort By:
Page
of 22
The Journal of Experimental Medicine
|
October 31, 2023
First-in-human therapy with Treg produced from thymic tissue (thyTreg) in a heart transplant infant
Esther Bernaldo-de-Quirós, Manuela Camino, Marta Martínez-Bonet, et al.
Therapeutic Advances in Musculoskeletal Disease
|
August 4, 2022
Risk of ischaemic stroke among new users of glucosamine and chondroitin sulphate: a nested case-control study
Ramón Mazzucchelli, Sara Rodríguez-Martín, Natalia Crespí-Villarías, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 18, 2022
Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma
Agostina Stradella, Pablo Gargallo, Mónica Cejuela, et al.
Data in Brief
|
July 17, 2025
PCPAm - A dataset of histopathological images of penile cancer for classification tasks
Marcos Gabriel Mendes Lauande, Geraldo Braz Júnior, João Dallyson Sousa de Almeida, et al.
Oncotarget
|
October 27, 2015
FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies
Antonio Martínez-Aranda, Vanessa Hernández, Emre Guney, et al.
Breast Cancer Research and Treatment
|
February 7, 2018
First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2- advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial
Wolfgang Janni, Emilio Alba, Thomas Bachelot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 6, 2022
Pre-operative ribociclib plus letrozole versus chemotherapy: Health-related quality of life outcomes from the SOLTI CORALLEEN trial
Guillermo Villacampa, Claudette Falato, Laia Paré, et al.
Neuro-Oncology
|
June 3, 2017
Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification
Juan Manuel Sepúlveda-Sánchez, María Ángeles Vaz, Carmen Balañá, et al.
Frontiers in Immunology
|
June 2, 2022
A Novel GMP Protocol to Produce High-Quality Treg Cells From the Pediatric Thymic Tissue to Be Employed as Cellular Therapy
Esther Bernaldo-de-Quirós, Beatriz Cózar, Rocío López-Esteban, et al.
Breast Cancer Research and Treatment
|
July 10, 2012
Efficacy and safety of concurrent trastuzumab plus weekly paclitaxel-FEC as primary therapy for HER2-positive breast cancer in everyday clinical practice
Sonia Pernas, Miguel Gil-Gil, María Ochoa de Olza, et al.
Page
of 22